Kolon Life Science (102940.KQ) Earnings Analysis
Kolon Life Science (102940.KQ) has no confirmed upcoming earnings date. Trailing P/E 6.76.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 102940.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 102940.KQ. This page updates as the calendar is published.
102940.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-16 | -741.91 KRW | n/a | n/a | n/a |
| 2025-08-18 | -120.03666 KRW | n/a | n/a | n/a |
| 2025-05-15 | 846.4 KRW | n/a | n/a | n/a |
| 2025-02-18 | -1,351.46042 KRW | n/a | n/a | n/a |
| 2024-11-14 | -1,009.00001 KRW | n/a | n/a | n/a |
| 2024-08-14 | -5,146.99985 KRW | n/a | n/a | n/a |
102940.KQ valuation and analyst view
| Trailing P/E | 6.76 |
|---|---|
| Trailing EPS | 2,711.23 KRW |
| Price / book | 0.31 |
| Dividend yield | 0.00% |
| Market cap | 228.95B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Kolon Life Science (102940.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 102940.KQ. This page updates as the calendar is published.
Did 102940.KQ beat earnings last quarter?
Consensus estimate data was not available for 102940.KQ's 2026-02-16 report.
What is 102940.KQ's current P/E ratio and EPS?
102940.KQ trades at a trailing P/E of 6.76 on trailing EPS of 2711.2322333077514 KRW.
What do analysts rate 102940.KQ?
102940.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.